Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy

Taku Fujimura, Yumi Kambayashi, Yota Sato, Kayo Tanita, Hisayuki Tono, Chunbing Lyu, Toshiya Takahashi, Akira Hashimoto, Setsuya Aiba

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)e260
JournalJournal of Dermatology
Volume46
Issue number7
DOIs
Publication statusPublished - 2019 Jul

ASJC Scopus subject areas

  • Dermatology

Cite this